ASPSCR1 and neoplasm: The t(X;17)(p11;q25) translocation not only results in the ASPSCR1-TFE3 fusion but also drives the abnormal activation of MET and PI3K/AKT signaling pathways (54), generating fusion proteins with oncogenic potential that promote tumor growth and metastasis.